KLK8 (Kallikrein Related Peptidase 8) has presented its research value in the prognosis of various cancers, such as lung cancer [17], ovarian cancer [18], breast cancer [19], colon cancer, and rectal cancer [20]. Here, KLK8 is linked to breast carcinoma.